| | |
All patients (n = 153)
|
Without HSV reactivation (n = 113)
|
HSV reactivation (n = 40)
|
p-value
|
|---|
|
Length of stay ICU
|
Median (IQR)
|
11.5 [7; 21.5]
|
9 [6; 15]
|
23 [17; 40]
|
< 0.001
|
|
Death in ICU
|
Number (%)
|
57 (37.3)
|
36 (31.9)
|
21 (52.5)
|
0.024
|
|
Death at day 60
|
Number (%)
|
61 (39.9)
|
38 (33.6)
|
23 (57.5)
|
0.014
|
|
HAP/VAP
|
Number (%)
|
67 (43.8)
|
34 (30.1)
|
33 (82.5)
|
< 0.001
|
|
ICU-BSI
|
Number (%)
|
38 (24.8)
|
20 (17.7)
|
18 (45)
|
0.001
|
|
IMV/ECMO
|
Number (%)
|
89 (58.2)
|
54 (47.8)
|
35 (87.5)
|
< 0.001
|
- HSV-positive and -negative patients were compared with Chi-square, Fisher and Wilcoxon tests
- HSV Herpes simplex virus; IQR Interquartile range; ICU Intensive Care Unit; HAP Hospital-acquired pneumonia; VAP Ventilator-associated pneumonia; ICU-BSI Intensive care unit bloodstream infection. IMV Invasive mechanical ventilation. ECMO Extra-Corporeal Membrane Oxygenation
